VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 225 filers reported holding VIR BIOTECHNOLOGY INC in Q4 2022. The put-call ratio across all filers is 0.43 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,519,139 | +160.9% | 162,128 | +582.9% | 0.01% | +140.0% |
| Q2 2023 | $582,366 | -6.5% | 23,741 | -3.5% | 0.01% | 0.0% |
| Q4 2022 | $622,626 | -55.2% | 24,600 | -65.9% | 0.01% | -58.3% |
| Q3 2022 | $1,390,000 | -12.4% | 72,095 | +15.7% | 0.01% | -20.0% |
| Q2 2022 | $1,587,000 | +413.6% | 62,300 | +419.7% | 0.02% | +400.0% |
| Q1 2022 | $309,000 | -65.4% | 11,987 | -43.7% | 0.00% | -62.5% |
| Q4 2021 | $892,000 | – | 21,300 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 1,559,142 | $30,100,000 | 23.79% |
| SB INVESTMENT ADVISERS (UK) LTD | 22,086,280 | $425,823,000 | 3.26% |
| Zebra Capital Management LLC | 40,104 | $773,000 | 2.94% |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 130,409 | $2,514,000 | 0.94% |
| CLARK ESTATES INC/NY | 180,000 | $3,470,000 | 0.77% |
| Temasek Holdings (Private) Ltd | 6,036,821 | $116,389,909 | 0.70% |
| SECTOR GAMMA AS | 89,808 | $1,731,000 | 0.45% |
| Capital Impact Advisors, LLC | 13,196 | $360,000 | 0.36% |
| SummerHaven Investment Management, LLC | 24,927 | $481,000 | 0.33% |
| DUALITY ADVISERS, LP | 92,712 | $1,787,000 | 0.20% |